24 research outputs found
Differential permissivity of human cerebrovascular endothelial cells to enterovirus infection and specificities of enterovirus 71 in crossing an in vitro model of human blood brain barrier
Human cerebral microvascular endothelial cells (hCMEC/D3 cell line) form a steady polarized barrier when cultured in vitro on a permeable membrane. Their susceptibility to enterovirus (EV) strains was analysed to investigate how these viruses may cross the blood-brain barrier. A sample of 88 virus strains was selected on phylogenetic features among 44 epidemiologically relevant types of the four EV species A-D. The EV-A71 genome was replicated at substantial rates while the infectious virus was released at extremely low but sustained rates at both barrier sides for at least 4 days. EV-A71 antigens were detected in a limited number of cells. The properties of the endothelial barrier (structure and permeability) remained intact throughout infection. The chronic EV-A71 infection was in sharp contrast with the productive infection of cytolytic EVs (e.g. echoviruses 6 and 30). The hCMEC/D3 barriers infected with the latter EVs exhibited elevated proportions of apoptotic and necrotic cells, which resulted in major injuries to the endothelial barriers with dramatic increase of paracellular permeability and virus crossing to the abluminal side. The following intracellular rearrangements were also seen: early destruction of the actin cytoskeleton, remodelling of intracellular membranes, and reorganization of the mitochondrion network in a small cluster near the perinuclear space
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
In an international cohort of 279 patients with hypoxemic influenza pneumonia, we identified 13 patients (4.6%) with autoantibodies neutralizing IFN-alpha and/or -omega, which were previously reported to underlie 15% cases of life-threatening COVID-19 pneumonia and one third of severe adverse reactions to live-attenuated yellow fever vaccine. Autoantibodies neutralizing type I interferons (IFNs) can underlie critical COVID-19 pneumonia and yellow fever vaccine disease. We report here on 13 patients harboring autoantibodies neutralizing IFN-alpha 2 alone (five patients) or with IFN-omega (eight patients) from a cohort of 279 patients (4.7%) aged 6-73 yr with critical influenza pneumonia. Nine and four patients had antibodies neutralizing high and low concentrations, respectively, of IFN-alpha 2, and six and two patients had antibodies neutralizing high and low concentrations, respectively, of IFN-omega. The patients' autoantibodies increased influenza A virus replication in both A549 cells and reconstituted human airway epithelia. The prevalence of these antibodies was significantly higher than that in the general population for patients 70 yr of age (3.1 vs. 4.4%, P = 0.68). The risk of critical influenza was highest in patients with antibodies neutralizing high concentrations of both IFN-alpha 2 and IFN-omega (OR = 11.7, P = 1.3 x 10(-5)), especially those <70 yr old (OR = 139.9, P = 3.1 x 10(-10)). We also identified 10 patients in additional influenza patient cohorts. Autoantibodies neutralizing type I IFNs account for similar to 5% of cases of life-threatening influenza pneumonia in patients <70 yr old
Endoscopic submucosal dissection with early multitraction placed before circumferential incision allows excellent exposure but with a risk of catching the muscularis propria
International audienc
Non-granular laterally spreading tumors: potential superficial cancers that artificial intelligence does not easily detect
International audienc
Coordinated prospective follow-up of Lynch syndrome is able to detect the majority of incident cancers
International audienc
Endoscopic Submucosal Dissection of High-Grade Dysplasia Recurrence in Ulcerative Colitis Using a Multitraction Technique.
International audienc
An unusual cause of abdominal obstruction in a 10-year-old boy successfully treated by endoscopy.
International audienceNo abstract availabl
Diagnostic endoscopic submucosal dissection for invasive cancer with the four cardinal points traction strategy.
International audienc
Bilan de la recherche et des activités subventionnées dans le domaine des applications pédagogiques de l'ordinateur au Québec de 1984 à 1986 /
(rel. Ă l'anglaise)Ăgalement disponible en version Ă©lectroniqueBibliogr.: p. 95-99
Endoscopic submucosal dissection combined with clip for closure of gastrointestinal fistulas including those refractory to previous therapy
International audienceBackgroundâGastrointestinal (GI) fistula is a life-threatening condition and a therapeutic challenge. Endoscopic approaches include mucosal abrasion, clip closure, or stent diversion, with moderate success rates in the long term. We assessed whether fistula endoscopic submucosal dissection with clip closure (FESDC) could lead to complete resolution of fistulas even after failure of previous endoscopic therapy. MethodsâPatients with GI fistulas, including those with previous failed treatment, were retrospectively included. The primary outcome was long-term (>â3 months) success of fistula healing. Secondary outcomes included technical success, safety, and factors associated with FESDC success. Resultsâ23 patients (13 refractory 57â%) were included. Tight immediate sealing was achieved in 19 patients (83â%; 95â% confidence interval [CI] 61â%â95â%). Long-term closure was achieved in 14 patients (61â%; 95â%CI 39â%â80â%), with median follow-up of 20 months. Complications occurred in two patients (9â%). Previous local malignancy (Pâ=â0.08) and radiotherapy (Pâ=â0.047) were associated with a higher risk of failure. ConclusionâThis novel FESDC strategy was demonstrated to be safe and feasible for permanent endoscopic closure of GI fistulas. Further studies are warranted to determine the place of this technique in the management of chronic GI fistula